{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260618193337/en/European-Commission-Approves-Trodelvy%C2%AE-as-a-First-Line-Treatment-for-Metastatic-Triple-Negative-Breast-Cancer-Patients-Not-Candidates-for-PD--l-1-Inhibitors", "message": "News view counter 811415 successfully enlarged"}